Skip to main content

Table 2 Baseline characteristics by SLCO1B1 diplotype group

From: Influence of SLCO1B1 and CYP2C8gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers

 

Group 1 n= 6

Group 2 n= 7

Group n= 13

SLCO1B1 diplotypes

*1A/*1A, n = 6

*1A/*1B, n = 4

*1A/*15, n = 2

  

*1B/*1B, n = 3

*1A/*16, n = 2

   

*1A/*17, n = 2

   

*1B/*15, n = 1

   

*1B/*16, n = 1

   

*1B/*17, n = 2

   

*5/*15, n = 1

   

*15/*16, n = 1

   

*17/*21, n = 1

Age (years)

33.8 ± 10.8

34.9 ± 12.1

31.3 ± 7.3

Weight (kg)

65.9 ± 14

65.3 ± 9.6

67.5 ± 12.5

Women, n

5

7

10

  1. Data are presented as mean ± SD or number.